Leading Quality Control operations for biopharmaceutical company Kyverna Therapeutics. Overseeing compliance and strategic leadership in cell therapy development and commercialization.
KT
Kyverna Therapeutics
Currently Hiring
About the company
Kyverna Therapeutics is a clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune and inflammatory diseases.
The Kyverna therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases.
Kyverna’s pipeline includes KYV-101, a fully human, autologous chimeric antigen receptor (CAR) T-cell therapy with properties well suited for use in B cell-driven autoimmune diseases and KYV-201, a fully human, allogeneic CAR T-cell therapy.
By offering more than one mechanism for taming autoimmunity, and with patients currently in treatment for multiple indications in the U.S.
and Europe, Kyverna is positioned to act on its mission of transforming how autoimmune diseases are treated.
Open jobs
Browse and apply for open jobs at Kyverna Therapeutics.
2 jobs found
VP leading global Quality functions across biopharmaceutical operations. Developing and maintaining GxP Quality frameworks to ensure compliance and patient safety.